BlackRock’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.05M Sell
2,260,748
-9,192,557
-80% -$8.34M ﹤0.01% 3981
2025
Q1
$5.17M Buy
11,453,305
+1,358,628
+13% +$614K ﹤0.01% 3592
2024
Q4
$5.07M Buy
10,094,677
+174,877
+2% +$87.9K ﹤0.01% 3680
2024
Q3
$8.98M Buy
9,919,800
+360,334
+4% +$326K ﹤0.01% 3420
2024
Q2
$9.53M Buy
9,559,466
+1,065,071
+13% +$1.06M ﹤0.01% 3362
2024
Q1
$12.6M Sell
8,494,395
-37,103
-0.4% -$54.9K ﹤0.01% 3180
2023
Q4
$9.3M Sell
8,531,498
-756,536
-8% -$825K ﹤0.01% 3363
2023
Q3
$11M Buy
9,288,034
+275,970
+3% +$326K ﹤0.01% 3224
2023
Q2
$12.7M Buy
9,012,064
+5,302,486
+143% +$7.48M ﹤0.01% 3232
2023
Q1
$5.56M Sell
3,709,578
-74,234
-2% -$111K ﹤0.01% 3506
2022
Q4
$4.43M Buy
3,783,812
+79,425
+2% +$92.9K ﹤0.01% 3712
2022
Q3
$4.19M Sell
3,704,387
-51,370
-1% -$58K ﹤0.01% 3754
2022
Q2
$5.93M Sell
3,755,757
-6,053,366
-62% -$9.56M ﹤0.01% 3668
2022
Q1
$15.1M Sell
9,809,123
-199,387
-2% -$307K ﹤0.01% 3275
2021
Q4
$24.5M Buy
10,008,510
+1,456,810
+17% +$3.57M ﹤0.01% 3103
2021
Q3
$21.6M Buy
8,551,700
+12,170
+0.1% +$30.7K ﹤0.01% 3174
2021
Q2
$24.3M Buy
8,539,530
+6,076,041
+247% +$17.3M ﹤0.01% 3131
2021
Q1
$5.79M Buy
2,463,489
+862,667
+54% +$2.03M ﹤0.01% 3811
2020
Q4
$2.82M Buy
1,600,822
+9,957
+0.6% +$17.5K ﹤0.01% 3849
2020
Q3
$1.49M Sell
1,590,865
-3,712
-0.2% -$3.48K ﹤0.01% 3887
2020
Q2
$1.39M Sell
1,594,577
-5,732,754
-78% -$4.99M ﹤0.01% 3865
2020
Q1
$6.07M Buy
7,327,331
+35,350
+0.5% +$29.3K ﹤0.01% 3210
2019
Q4
$6.49M Buy
7,291,981
+2,439
+0% +$2.17K ﹤0.01% 3384
2019
Q3
$7.14M Buy
7,289,542
+198,358
+3% +$194K ﹤0.01% 3335
2019
Q2
$7.8M Sell
7,091,184
-127,620
-2% -$140K ﹤0.01% 3322
2019
Q1
$9.46M Buy
7,218,804
+1,039,523
+17% +$1.36M ﹤0.01% 3123
2018
Q4
$5.64M Sell
6,179,281
-795,839
-11% -$727K ﹤0.01% 3336
2018
Q3
$14.3M Buy
6,975,120
+212,456
+3% +$437K ﹤0.01% 3022
2018
Q2
$12.2M Buy
6,762,664
+660,653
+11% +$1.19M ﹤0.01% 3110
2018
Q1
$14.4M Buy
6,102,011
+48,652
+0.8% +$115K ﹤0.01% 2919
2017
Q4
$11.4M Buy
6,053,359
+220,644
+4% +$415K ﹤0.01% 3056
2017
Q3
$14.5M Buy
5,832,715
+74,823
+1% +$186K ﹤0.01% 2930
2017
Q2
$15.9M Buy
5,757,892
+155,708
+3% +$429K ﹤0.01% 2879
2017
Q1
$16.9M Buy
5,602,184
+5,596,562
+99,548% +$16.9M ﹤0.01% 2826
2016
Q4
$18K Sell
5,622
-676
-11% -$2.16K ﹤0.01% 3221
2016
Q3
$21K Buy
6,298
+1,462
+30% +$4.88K ﹤0.01% 3211
2016
Q2
$11K Buy
4,836
+1,008
+26% +$2.29K ﹤0.01% 3356
2016
Q1
$10K Buy
3,828
+2,533
+196% +$6.62K ﹤0.01% 3106
2015
Q4
$4K Hold
1,295
﹤0.01% 3175
2015
Q3
$3K Hold
1,295
﹤0.01% 3091
2015
Q2
$4K Hold
1,295
﹤0.01% 3110
2015
Q1
$5K Buy
+1,295
New +$5K ﹤0.01% 2988
2014
Q2
Sell
-1,658
Closed -$4K 3136
2014
Q1
$4K Hold
1,658
﹤0.01% 3061
2013
Q4
$5K Hold
1,658
﹤0.01% 3007
2013
Q3
$5K Hold
1,658
﹤0.01% 2972
2013
Q2
$5K Buy
+1,658
New +$5K ﹤0.01% 3017